Tenax Therapeutics Inc (TENX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TENX Annual Balance Sheets →
A period-by-period view of the balance sheet from Tenax Therapeutics Inc to Jun 30 2025 helps clarify how Jun 30 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent118.00
Cash & Short-term Investments118.00
Other Current Assets0.25
Prepaid Expense, Current AS3.42
Total Current Assets121.66
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents118.76
Total Assets121.66
Liabilities
Accounts Payable, Current AC1.28
Accrued Liabilities, Current AC1.28
Other Liabilities, Current5.52
Total Current Liabilities8.07
Total Long-term Debt0.00
Total Liabilities8.07
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock514.56
Retained Earnings / Accumulated Deficit-401.00
Other Equity0.00
Common Stockholder's Equity113.59
Total Stockholder's Equity113.59
Liabilities & Stockholder's Equity121.66
4 historic quarters locked

Sign in to unlock the full Tenax Therapeutics Inc balance sheet history.

About Tenax Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-327455

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.